Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

RTFCCR-MRA Team Science Awards On Patient-Centric Melanoma Clinical Trials

Melanoma Research Alliance

MRA is the largest non-profit funder of melanoma research. MRA’s investment in the field has been critical in catalyzing transformative, strategic, and collaborative investments in scientific discovery and translation.

Each year, MRA selects new research awards to address critical unmet needs in melanoma detection, prognostication, and treatment. All grant awards are selected by MRA’s Grant Review Committee through a diligent peer review process and are confirmed by our Board of Directors. To date, MRA has invested over $150 million in life-saving melanoma research, and leveraged an additional $415 million in collaborative and follow-on funding towards its mission.

The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment.

This cycle, proposals will be accepted for Established Investigator Awards, Academic-Industry Partnership Award (for Established Investigator Awards), Young Investigator Awards, Pilot Awards, Dermatology Career Development Awards and Special Opportunity Team Science Awards, Academic-Industry Partnership Award (for Special Opportunity Team Science Awards).

MRA plans to support at least $9.2 million in new funding in the 2024-2025 cycle.

September 27, 2024: Letters of Intent (LOI) for Special Opportunity Team Science Awards and Special Opportunity Team Science Academic-Industry Partnership Award due

October 21, 2024: Eligibility Checklist for Young Investigator & Dermatology Career Development Award applicants due
November 4, 2024: Proposals for Established Investigator, Young Investigator, Pilot and Dermatology Career Development awards due
January 6, 2025: Invited Special Opportunity Team Science Award full proposals due
April 2025: Awardees notified of funding decisions
June 1, 2025: Project Start Date

All proposals are due by 11:59 pm Eastern Time. Proposals should be submitted via the proposalCENTRAL online application tool: https://proposalcentral.com/

Specialties

Cancer

Oncology

Dermatology

Eligibility Requirements

Special Opportunities Included in RFP:

Acral Melanoma Established Investigator, Young Investigator, & Pilot Awards focused on Advancing Translational Research for Acral Melanoma 
Uveal Melanoma Established Investigator and Young Investigator Awards focused on Advancing Translational Research for Uveal Melanoma
Uveal Melanoma Pilot Award co-funded with A Cure in Sight (ACIS)
Team Science and Established Investigator Awards in Pediatric Melanoma co-funded with St. Baldrick's Foundation
Team Science Award for Translational Research Opportunities from Patients Receiving Neoadjuvant Treatment Approaches
Radiation Oncology Young Investigator Award co-funded with the American Society for Radiation Oncology (ASTRO)
Young Investigator Award (YIA) proposals from applicants based in Australia, Israel, or the United Kingdom (UK)

Eligible Countries:

Australia

Israel

United Kingdom

Sponsor Details

Sponsor Institute/Organizations: Melanoma Research Alliance

Address: 730 15th Street, NW Washington, DC 20005 (202) 336-8935 info@curemelanoma.org

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity